Back to Journals » Journal of Hepatocellular Carcinoma » Volume 6 » default
![](https://www.dovepress.com/cr_data/cache/journal_image/148/cope/thumb_100_1000_100.jpg)
Journal of Hepatocellular Carcinoma
ISSN: 2253-5969
- View all (625)
- Volume 11, 2024 (101)
- Volume 10, 2023 (176)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Archive: Volume 6, 2019
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/OjaWtKLEttw/1.jpg)
El Kassas M, Tawheed A, Eltabbakh M, Kaseb A
Journal of Hepatocellular Carcinoma 2019, 6:183-191
Published Date: 19 November 2019
Socioeconomic And Survival Differences Among Minorities With Hepatocellular Carcinoma In Florida
Jones PD, Scheinberg AR, Muenyi V, Gonzalez-Diaz J, Martin PM, Kobetz E
Journal of Hepatocellular Carcinoma 2019, 6:167-181
Published Date: 15 November 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine
Duan J, Wu Y, Liu J, Zhang J, Fu Z, Feng T, Liu M, Han J, Li Z, Chen S
Journal of Hepatocellular Carcinoma 2019, 6:151-166
Published Date: 18 October 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Hepatitis B And Hepatitis C Viral Infections And Associated Factors Among Patients With Diabetes Visiting Gondar Referral Teaching Hospital, Northwest Ethiopia: A Comparative Cross-Sectional Study
Million Y, Teklu T, Alemu S, Ferede A, Belachew T, Desta K
Journal of Hepatocellular Carcinoma 2019, 6:143-150
Published Date: 8 October 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Status of, and strategies for improving, adherence to HCC screening and surveillance
Francica G, Borzio M
Journal of Hepatocellular Carcinoma 2019, 6:131-141
Published Date: 24 July 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma
Zakka K, Jiang R, Alese OB, Shaib WL, Wu C, Wedd JP, Sellers MT, Behera M, El-Rayes BF, Akce M
Journal of Hepatocellular Carcinoma 2019, 6:119-129
Published Date: 22 July 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Intermediate stage hepatocellular carcinoma: a summary review
Elshaarawy O, Gomaa A, Omar H, Rewisha E, Waked I
Journal of Hepatocellular Carcinoma 2019, 6:105-117
Published Date: 11 July 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve
Fidelman N, Johanson C, Kohi MP, Kolli KP, Kohlbrenner RM, Lehrman ED, Taylor AG, Kelley RK, Yao FY, Roberts JP, Kerlan RK
Journal of Hepatocellular Carcinoma 2019, 6:93-103
Published Date: 17 June 2019
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinoma
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/YCfD3s4OVcQ/1.jpg)
Delgado TC, Lopitz-Otsoa F, Martínez-Chantar ML
Journal of Hepatocellular Carcinoma 2019, 6:85-91
Published Date: 6 June 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives
Lu LC, Chang CJ, Hsu CH
Journal of Hepatocellular Carcinoma 2019, 6:71-84
Published Date: 7 May 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance
![](cr_data/cache/submission_images/s186000/186239/16b_200_200_90.jpg)
Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB
Journal of Hepatocellular Carcinoma 2019, 6:49-69
Published Date: 5 February 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Road map for fibrolamellar carcinoma: progress and goals of a diversified approach
Kastenhuber ER, Craig J, Ramsey J, Sullivan KM, Sage J, de Oliveira S, Riehle KJ, Scott JD, Gordan JD, Bardeesy N, Abou-Alfa GK
Journal of Hepatocellular Carcinoma 2019, 6:41-48
Published Date: 31 January 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
Personeni N, Pressiani T, Rimassa L
Journal of Hepatocellular Carcinoma 2019, 6:31-39
Published Date: 31 January 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms
Geh D, Rana FA, Reeves HL
Journal of Hepatocellular Carcinoma 2019, 6:23-30
Published Date: 14 January 2019
![Noteworthy comment: Combined hepatocellular carcinoma-cholangiocarcinoma is a rare entity and the article provides important input about relevant clinical issues in routine practice and also in research areas related to this entity.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions
Stavraka C, Rush H, Ross P
Journal of Hepatocellular Carcinoma 2019, 6:11-21
Published Date: 28 December 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria
Amado V, Rodríguez-Perálvarez M, Ferrín G, De la Mata M
Journal of Hepatocellular Carcinoma 2019, 6:1-10
Published Date: 21 December 2018